Illustrative

FDA Approves Maintenance Combo for Small Cell Lung Cancer

MedPage Today·Oct 3

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA has approved a combination treatment for maintenance use in small cell lung cancer. This approval is for a specific combination of therapies to be used in a maintenance setting for this type of cancer. The treatment is intended for maintenance use in small cell lung cancer patients.

Full coverage

With FDA approval, Jazz and Roche's combo sets new bar in first-line small cell lung cancer

Fierce Pharma·Oct 3

FDA Approves Lurbinectedin (Zepzelca) Combination for Extensive-Stage Small Cell Lung Cancer

Oncology News Central·Oct 3

FDA Approves Zepzelca Plus Tecentriq for Extensive-Stage Small Cell Lung Cancer

Cure Today·Oct 2

FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC

CancerNetwork·Oct 2

Dr Sabari on the FDA Approval of Maintenance Lurbinectedin Plus Atezolizumab for ES-SCLC

OncLive·Oct 2

Fetching the latest headlines…